Melanocortin Receptors and Erectile Function
FDA Approval of Bremelanotide for Female Sexual Desire Disorder Changes Market
The company said in a statement that it does not know the drug’s exact mechanism of action, but “Vyleesi is believed to bind to melanocortin receptors in the central nervous system that are thought to be associated with sexual function.”